Related Experiment Videos
Inhibitors of the complement system currently in development for cardiovascular disease
M K Pugsley1, M Abramova, T Cole
1Department of Pharmacology, XOMA (US) LLC, Berkeley, CA 94710, USA. pugsley@xoma.com
Cardiovascular Toxicology
|April 2, 2003
Summary
The complement system, crucial for immunity, can cause organ damage if improperly activated. This review explores complement pathways, regulation, cardiovascular roles, and therapeutic inhibitors for immune system control.
Area of Science:
- Immunology
- Biochemistry
- Cardiovascular Medicine
Background:
- The complement system is vital for host defense against pathogens.
- Dysregulated complement activation can lead to severe organ damage.
- Understanding complement control is key to managing inflammatory responses.
Purpose of the Study:
- To review complement system activation pathways and regulatory mechanisms.
- To examine the role of complement in cardiovascular diseases, including ischemia-reperfusion injury and cardiopulmonary bypass.
- To provide an overview of current and developing complement inhibitors as therapeutic agents.
Main Methods:
- Literature review of complement system pathways and regulation.
- Analysis of complement's involvement in cardiovascular pathologies.
- Survey of existing and emerging complement-targeting therapies.
Main Results:
- Detailed explanation of complement activation cascades (classical, lectin, alternative).
- Elucidation of intrinsic and extrinsic control mechanisms for complement.
- Evidence linking complement activation to myocardial ischemia-reperfusion injury and cardiopulmonary bypass complications.
Conclusions:
- Controlled complement activation is essential for immunity, but dysregulation causes disease.
- Targeting complement pathways offers promising therapeutic strategies for cardiovascular and inflammatory conditions.
- A range of complement inhibitors are progressing through discovery and clinical development.